Cite
HARVARD Citation
Komiyama, S. et al. (2018). Safety and efficacy of neoadjuvant chemotherapy containing bevacizumab and interval debulking surgery for advanced epithelial ovarian cancer: A feasibility study. Journal of surgical oncology. 118 (4), pp. 687-693. [Online].